Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) has a beta value of 0.98 and has seen 9.29 million shares traded in the recent trading session. The company, currently valued at $0.62M, closed the recent trade at $0.92 per share which meant it gained $0.05 on the day or 5.19% during that session. The BDRX stock price is -3160.87% off its 52-week high price of $30.00 and 15.22% above the 52-week low of $0.78. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.17 million shares traded. The 3-month trading volume is 2.24 million shares.

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information

Over the past 30 days, the shares of Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) have changed -18.64%. Short interest in the company has seen 0.18 million shares shorted with days to cover at 0.06.

Biodexa Pharmaceuticals Plc ADR (BDRX) estimates and forecasts

The company’s shares have lost -78.47% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 83.98% over the past 5 years.

BDRX Dividends

Biodexa Pharmaceuticals Plc ADR is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s Major holders

Insiders own 1.17% of the company shares, while shares held by institutions stand at 7.70% with a share float percentage of 7.79%. Investors are also buoyed by the number of investors in a company, with Biodexa Pharmaceuticals Plc ADR having a total of 13.0 institutions that hold shares in the company.